What should you teach about tiotropium (Spiriva) when prescribing it for a client with COPD?

Tiotropium (Spiriva) is a long-acting anticholinergic medication commonly prescribed for patients with Chronic Obstructive Pulmonary Disease (COPD). One of the key points to communicate to patients is that it should be used once daily. This dosing schedule is crucial because tiotropium works to open the airways and improve breathing over a prolonged period, providing consistent relief of COPD symptoms. Taking it just once a day allows for stable and effective management of airway constriction without the need for frequent dosing, which can help improve adherence to the treatment regimen.

The other choices suggest either inappropriate use or misunderstanding of the medication's role. Using tiotropium every time a beta-2 agonist is used does not reflect the intended schedule or purpose of each medication. Stopping all other COPD medications without healthcare provider guidance could lead to exacerbation of the disease. Lastly, while dry mouth can be a side effect of tiotropium, it does not necessitate stopping the medication abruptly, as other management strategies may be possible. Emphasizing the once-daily dosing aligns with the medication's pharmacological properties and best practices for managing COPD.